These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1674 related articles for article (PubMed ID: 8510874)

  • 21. An in vitro model for the scintigraphic detection of thrombi using a 99Tcm-labelled antifibrin monoclonal antibody.
    Wasser MN; Cleyndert P; Camps JA; Feitsma RI; Nieuwenhuizen W; Pauwels EK
    Nucl Med Commun; 1989 Sep; 10(9):653-9. PubMed ID: 2616104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate.
    Petrov AD; Narula J; Nakazawa A; Pak KY; Khaw BA
    Nucl Med Commun; 1997 Mar; 18(3):241-51. PubMed ID: 9106778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin.
    Gratz S; Behr TM; Herrmann A; Meller J; Conrad M; Zappel H; Becker W
    Nucl Med Commun; 1998 Nov; 19(11):1037-45. PubMed ID: 9861620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
    Li N; Yu L; Zhang C
    Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
    Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
    Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybridization of a 99Tcm-labelled oligodeoxynucleotide to CAPL RNA.
    Hjelstuen OK; Maelandsmo GM; Tønnesen HH; Bremmer PO; Verbruggen AM
    Nucl Med Commun; 1998 Aug; 19(8):803-12. PubMed ID: 9751936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoscintigraphy: Importance for researchers and patients.
    Britton KE; Granowska M
    Acta Oncol; 1996; 35(3):313-7. PubMed ID: 8679262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 99Tcm-labelled human immunoglobulin in animal models of experimentally induced inflammatory lesions.
    Shimpi HH; Noronha OP; Samuel AM
    Nucl Med Commun; 1995 Oct; 16(10):846-52. PubMed ID: 8570115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.
    Modorati G; Brancato R; Paganelli G; Magnani P; Pavoni R; Fazio F
    Br J Ophthalmol; 1994 Jan; 78(1):19-23. PubMed ID: 8110692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoscintigraphy of carcinomas in the area of the head-neck with technetium-99m marked monoclonal antibody 174H.64. A new diagnostic procedure].
    Kiefer J; Baum RP; Knecht R; Hertel A; Niesen A; von Ilberg C; Hör G
    HNO; 1994 Sep; 42(9):546-52. PubMed ID: 7989226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
    Behr T; Becker W; Hannappel E; Wolf F
    Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 99Tcm-labelled monoclonal anti-granulocyte antibody and 111In-labelled IgG for the detection of focal sites of infection in rats.
    Juweid M; Fischman AJ; Rubin RH; Baum R; Strauss HW
    Nucl Med Commun; 1991 Jul; 12(7):637-44. PubMed ID: 1923155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoscintigraphy in malignant melanoma: a five-year clinical experience.
    Feggi L; Indelli M; Pansini GC; Santini A; Prandini N; Virgili AR
    Nucl Med Commun; 1993 Feb; 14(2):145-8. PubMed ID: 8429994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoscintigraphy with 99Tcm-monoclonal anti-granulocyte antibodies (BW 250/183) in inflammatory diseases.
    Moragas M; Lomeña F
    Nucl Med Commun; 1992 Dec; 13(12):898-9. PubMed ID: 1465275
    [No Abstract]   [Full Text] [Related]  

  • 35. Simultaneous administration of 99Tcm-HMPAO-labelled autologous leukocytes and 111In-labelled non-specific polyclonal human immunoglobulin G in bone and joint infections.
    de Lima Ramos PA; Martin-Comin J; Bajén MT; Roca M; Ricart Y; Castell M; Mora J; Puchal R; Ramos M
    Nucl Med Commun; 1996 Sep; 17(9):749-57. PubMed ID: 8895902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals.
    Bogsrud TV; Chen MN; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Jan; 20(1):61-5. PubMed ID: 9949414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 123I monoclonal granulocyte antibody and 99Tcm-HMPAO-labelled leucocytes in the detection of inflammation.
    Vorne M; Karhunen K; Lantto T; Mokka R; Mäkelä P; Nikoskelainen J; Rajamäki A
    Nucl Med Commun; 1988 Sep; 9(9):623-9. PubMed ID: 3186083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
    Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
    Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
    Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.